What is the price target for HOTH stock?
7 analysts have analysed HOTH and the average price target is 5.1 USD. This implies a price increase of 415.15% is expected in the next year compared to the current price of 0.99.
HOTH THERAPEUTICS INC (HOTH) Forecast, Price Target & Analyst Ratings
NASDAQ:HOTH • US44148G2049
Current stock price
0.99 USD
-0.05 (-4.81%)
At close:
0.98 USD
-0.01 (-1.01%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HOTH THERAPEUTICS INC (HOTH).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 26, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.10
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.10
Upside
+ 415.15%
From current price of $0.99 to mean target of $5.10, Based on 7 analyst forecasts
Low
$5.05
Median
$5.10
High
$5.25
Price Target Revisions
1 Month
0.00%
3 Months
11.11%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for HOTH. The average price target is 5.1 USD. This implies a price increase of 415.15% is expected in the next year compared to the current price of 0.99.
The average price target has been revised upward by 11.11% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
HOTH was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HOTH.
In the previous month the buy percentage consensus was at a similar level.
HOTH was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-30 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-23 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-10 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-11 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-11 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-09-05 | EF Hutton | Maintains | Buy -> Buy |
| 2024-08-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 26, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.10
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 68.13%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
HOTH is expected to report earnings on 3/26/2026. The consensus EPS estimate for the next earnings is -0.1 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 50.06% | N/A 33.38% | N/A 50.06% | N/A 16.71% | |||||||||
| EBITDA YoY % growth | -1.87M | -2.5M -33.69% | -7.72M -208.80% | -7.3M 5.44% | -14.1M -93.15% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.87M | -2.5M -33.69% | -7.72M -208.80% | -7.3M 5.44% | -14.1M -93.15% | -11.07M 21.49% | -7.692M 30.51% | -8.215M -6.80% | N/A -59.55% | N/A -40.14% | N/A -20.00% | N/A -71.22% | N/A 244.86% | N/A 98.49% | N/A 54.00% | N/A 76.00% | N/A 23.71% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -14.50 -7.97% | -16.50 -13.79% | -9.91 39.94% | -2.37 76.08% | -1.33 43.88% | N/A 60.12% | N/A -13.46% | N/A -18.64% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.10 68.13% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -3.157M -32.46% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
13.53%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
HOTH THERAPEUTICS INC / HOTH Forecast FAQ
When does HOTH THERAPEUTICS INC (HOTH) report earnings?
HOTH THERAPEUTICS INC (HOTH) will report earnings on 2026-03-26, after the market close.
Can you provide the consensus estimates for HOTH THERAPEUTICS INC next earnings?
The consensus EPS estimate for the next earnings of HOTH THERAPEUTICS INC (HOTH) is -0.1 USD and the consensus revenue estimate is 0 USD.
Can you provide the analyst count for HOTH THERAPEUTICS INC stock?
The number of analysts covering HOTH THERAPEUTICS INC (HOTH) is 7.